Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Stanford University · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
epstein-barr-virusnasopharyngeal-carcinoma
nasopharyngeal cancer, epstein-barr virus related carcinoma, epstein-barr virus, nasopharyngeal carcinoma, nasopharynx cancer, vk-2019, npc, ebna1 inhibitor, ebv, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1032857
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.